84
Views
3
CrossRef citations to date
0
Altmetric
Review

Prolonged low-dose infusion for gemcitabine: a systematic review

, , &
Pages 4859-4868 | Published online: 21 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lucia Ruxandra Tefas, Ioana Toma, Alina Sesarman, Manuela Banciu, Ancuta Jurj, Ioana Berindan-Neagoe, Lucia Rus, Rares Stiufiuc & Ioan Tomuta. (2023) Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer. Journal of Liposome Research 33:3, pages 234-250.
Read now
Mohd Sajid Ali, Jayaraman Muthukumaran, Monika Jain, Hamad A. Al-Lohedan, M. Abul Farah & Osama Ibrahim Alsowilem. (2022) Experimental and computational investigation on the binding of anticancer drug gemcitabine with bovine serum albumin. Journal of Biomolecular Structure and Dynamics 40:19, pages 9144-9157.
Read now

Articles from other publishers (1)

Hao Huang, Ling Peng, Bicheng Zhang, Brian G. Till, Yonghao Yang, Xiaojie Zhang, Lingdi Zhao, Xiaomin Fu, Tiepeng Li, Lu Han, Peng Qin, Lin Chen, Xiang Yan, Yang Liu, Wenkang Wang, Zhenlong Ye, Hongle Li, Quanli Gao & Zibing Wang. (2022) Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies. Frontiers in Immunology 13.
Crossref